---
layout: post
title: ipratropium bromide
scope: administer
version: pcp/7.1
---

## Generic Name

ipratropium bromide

## Trade Name

Atrovent®

## Classification

Bronchodilator, anticholinergic

## Indications

- Bronchospasm associated with chronic bronchitis and emphysema
- Bronchospasm associated with asthma
- COPD exacerbation

## Contraindications

- Hypersensitivity to atropine, soybean protein or peanuts
- Closed angle glaucoma
- Bladder neck obstruction
- Prostatic hypertrophy
- Hypersensitivity to the drug

## Precautions

Avoid getting in the eyes of patients especially those with glaucoma as it may lead to an increase in intra-ocular pressure by as much as 23% through muscles in your eyes relaxing

## Side Effects

- Palpitations
- Anxiety
- Dizziness
- Headache
- Nausea/vomiting
- Coughing
- Dry mouth
- Urinary retention
- Rash
- Nervousness

## Dose

### Adult:

250-500mcg/dose nebulized q(10-15) m(1500mcg)  
4-8 puffs (80-160mcg) w/spacer q(20min) m(30 puffs)

### Pediatric:

**> 12 yo:** Adult Dose  
**5-12 yo:** 125-250mcg/dose nebulized  
**< 20kg:** 250mcg nebulized PRN m(500mcg)  
**> 20kg:** 500mcg nebulized PRN m(1000mcg)

## Supplied

- 250 mcg in 1ml
- 20 mcg per metered dose in MDI

## Mechanism

Ipratropium is an anticholinergic which acts by blocking acetylcholine receptors, thus inhibiting parasympathetic stimulation.

This causes bronchodilation and dries respiratory tract secretions.

- Onset varies - usually > 5 minutes
- Peak effects within 1.5 - 2 hours
- Duration of 4 - 6 hours
- ½ life of 1.5 - 2 hours

## Notes

Always administer with Ventolin because the onset of effects of Atrovent is greater than 5 min
